# CSPPT- Chronic Kidney Diseases Study

> **NCT01871740** · PHASE4 · WITHDRAWN · sponsor: **Shenzhen Ausa Pharmed Co.,Ltd**

## Conditions studied

- Hypertension
- Hyperhomocysteinemia

## Interventions

- **DRUG:** Enalapril maleate and folic acid tablets
- **DRUG:** Enalapril maleate

## Key facts

- **NCT ID:** NCT01871740
- **Lead sponsor:** Shenzhen Ausa Pharmed Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The sponsor and the PIs both agreed that the CSPPT-CKD should be a sub-study of the CSPPT insted of an independent randomized trial.
- **Last updated:** 2016-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01871740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01871740, "CSPPT- Chronic Kidney Diseases Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01871740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*